Basic gene annotations are collected from Uniprot and displayed with links to original sources. A quick link to explore the genomic context with Uniprot Browser is available.
hsa-mir-98 -
Function
Uniprot Browser| Entrez ID | EnsEMBL ID | Preferred Name | Uniprot ID |
|---|---|---|---|
| - | hsa-mir-98 |
Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow, a mutation may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulonthat contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows with hsa-mir-98 as Regulator
| ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
|---|---|---|---|---|---|---|---|---|
| CMF-33923 | MYO7B | down-regulates | hsa-mir-98 | represses | R-2836 | 8 | 2 | Drugs (4) |
| CMF-33924 | MYO7B | down-regulates | hsa-mir-98 | represses | R-1613 | 8 | 2 | Drugs (4) |
| CMF-34505 | SSPO | up-regulates | hsa-mir-98 | represses | R-3603 | 8 | 1 | Drugs (3) |
| CMF-35357 | ATRX | up-regulates | hsa-mir-98 | represses | R-2053 | 8 | 8 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)DICHLORPHENAMIDE, ALEPLASININ, SULTHIAME, ACETAZOLAMIDE, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, ACETAZOLAMIDE SODIUM, VESENCUMAB |
| CMF-35358 | ATRX | up-regulates | hsa-mir-98 | represses | R-183 | 8 | 8 | Drugs (4) |
| CMF-35359 | ATRX | up-regulates | hsa-mir-98 | represses | R-646 | 8 | 8 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
| CMF-35360 | ATRX | up-regulates | hsa-mir-98 | represses | R-2836 | 8 | 8 | Drugs (4) |
| CMF-35361 | ATRX | up-regulates | hsa-mir-98 | represses | R-896 | 8 | 8 | Drugs (4) |
| CMF-35362 | ATRX | up-regulates | hsa-mir-98 | represses | R-3010 | 8 | 8 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)SULTHIAME, CILENGITIDE, SENICAPOC, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, ABITUZUMAB |
| CMF-35363 | ATRX | up-regulates | hsa-mir-98 | represses | R-1613 | 8 | 8 | Drugs (4) |
| CMF-35364 | ATRX | up-regulates | hsa-mir-98 | represses | R-3603 | 8 | 8 | Drugs (3) |
| CMF-36301 | MSL3 | up-regulates | hsa-mir-98 | represses | R-3603 | 8 | 1 | Drugs (3) |
| CMF-37918 | MYO1A | up-regulates | hsa-mir-98 | represses | R-3603 | 8 | 1 | Drugs (3) |
| CMF-38000 | XK | up-regulates | hsa-mir-98 | represses | R-3603 | 8 | 1 | Drugs (3) |
| CMF-39339 | DENND1C | up-regulates | hsa-mir-98 | represses | R-2836 | 8 | 3 | Drugs (4) |
| CMF-39340 | DENND1C | up-regulates | hsa-mir-98 | represses | R-896 | 8 | 3 | Drugs (4) |
| CMF-39341 | DENND1C | up-regulates | hsa-mir-98 | represses | R-1613 | 8 | 3 | Drugs (4) |
| CMF-40679 | IDH1 | up-regulates | hsa-mir-98 | represses | R-2053 | 8 | 8 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)DICHLORPHENAMIDE, ALEPLASININ, SULTHIAME, ACETAZOLAMIDE, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, ACETAZOLAMIDE SODIUM, VESENCUMAB |
| CMF-40680 | IDH1 | up-regulates | hsa-mir-98 | represses | R-183 | 8 | 8 | Drugs (4) |
| CMF-40681 | IDH1 | up-regulates | hsa-mir-98 | represses | R-646 | 8 | 8 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
| CMF-40682 | IDH1 | up-regulates | hsa-mir-98 | represses | R-2836 | 8 | 8 | Drugs (4) |
| CMF-40683 | IDH1 | up-regulates | hsa-mir-98 | represses | R-896 | 8 | 8 | Drugs (4) |
| CMF-40684 | IDH1 | up-regulates | hsa-mir-98 | represses | R-3010 | 8 | 8 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)SULTHIAME, CILENGITIDE, SENICAPOC, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, ABITUZUMAB |
| CMF-40685 | IDH1 | up-regulates | hsa-mir-98 | represses | R-1613 | 8 | 8 | Drugs (4) |
| CMF-40686 | IDH1 | up-regulates | hsa-mir-98 | represses | R-3603 | 8 | 8 | Drugs (3) |
| CMF-41588 | LTBP2 | up-regulates | hsa-mir-98 | represses | R-3603 | 8 | 1 | Drugs (3) |
| CMF-41857 | IQSEC3 | up-regulates | hsa-mir-98 | represses | R-2053 | 8 | 7 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)DICHLORPHENAMIDE, ALEPLASININ, SULTHIAME, ACETAZOLAMIDE, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, ACETAZOLAMIDE SODIUM, VESENCUMAB |
| CMF-41858 | IQSEC3 | up-regulates | hsa-mir-98 | represses | R-183 | 8 | 7 | Drugs (4) |
| CMF-41859 | IQSEC3 | up-regulates | hsa-mir-98 | represses | R-2836 | 8 | 7 | Drugs (4) |
| CMF-41860 | IQSEC3 | up-regulates | hsa-mir-98 | represses | R-896 | 8 | 7 | Drugs (4) |
| CMF-41861 | IQSEC3 | up-regulates | hsa-mir-98 | represses | R-3010 | 8 | 7 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)SULTHIAME, CILENGITIDE, SENICAPOC, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, ABITUZUMAB |
| CMF-41862 | IQSEC3 | up-regulates | hsa-mir-98 | represses | R-1613 | 8 | 7 | Drugs (4) |
| CMF-41863 | IQSEC3 | up-regulates | hsa-mir-98 | represses | R-3603 | 8 | 7 | Drugs (3) |
| CMF-42107 | CARD11 | up-regulates | hsa-mir-98 | represses | R-3010 | 8 | 1 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)SULTHIAME, CILENGITIDE, SENICAPOC, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, ABITUZUMAB |
| CMF-42126 | MAGEB1 | up-regulates | hsa-mir-98 | represses | R-2053 | 8 | 2 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)DICHLORPHENAMIDE, ALEPLASININ, SULTHIAME, ACETAZOLAMIDE, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, ACETAZOLAMIDE SODIUM, VESENCUMAB |
| CMF-42127 | MAGEB1 | up-regulates | hsa-mir-98 | represses | R-646 | 8 | 2 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
| CMF-42710 | DCC | up-regulates | hsa-mir-98 | represses | R-2053 | 8 | 2 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)DICHLORPHENAMIDE, ALEPLASININ, SULTHIAME, ACETAZOLAMIDE, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, ACETAZOLAMIDE SODIUM, VESENCUMAB |
| CMF-42711 | DCC | up-regulates | hsa-mir-98 | represses | R-183 | 8 | 2 | Drugs (4) |
| CMF-43137 | GABRA6 | up-regulates | hsa-mir-98 | represses | R-3603 | 8 | 1 | Drugs (3) |
| CMF-43245 | CYP2B6 | up-regulates | hsa-mir-98 | represses | R-2836 | 8 | 1 | Drugs (4) |